US Stock MarketDetailed Quotes
SGMO Sangamo Therapeutics
- 1.960
- +0.010+0.51%
Close Nov 21 16:00 ET
- 1.960
- 0.0000.00%
Post 16:00 ET
408.95MMarket Cap-2760P/E (TTM)
2.030High1.890Low3.28MVolume1.940Open1.950Pre Close6.44MTurnover1.61%Turnover RatioLossP/E (Static)208.65MShares3.17952wk High10.43P/B399.99MFloat Cap0.30452wk Low--Dividend TTM204.07MShs Float51.375Historical High--Div YieldTTM7.18%Amplitude0.291Historical Low1.961Avg Price1Lot Size
Sangamo Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -70.33%39.2M | -80.58%27.79M | -73.51%54.42M | -70.82%81M | -70.82%81M | -57.87%132.11M | -54.67%143.1M | -35.37%205.39M | -26.27%277.63M | -26.27%277.63M |
| -Cash and cash equivalents | -30.63%39.2M | -58.42%27.79M | -30.45%54.42M | -55.00%45.2M | -55.00%45.2M | -40.24%56.51M | -43.22%66.83M | -34.94%78.24M | -43.85%100.44M | -43.85%100.44M |
| -Short-term investments | --0 | --0 | --0 | -79.80%35.8M | -79.80%35.8M | -65.48%75.6M | -61.48%76.27M | -35.63%127.15M | -10.36%177.19M | -10.36%177.19M |
| Receivables | 499.77%10.5M | -85.24%581K | -91.42%691K | -70.35%1.33M | -70.35%1.33M | -65.32%1.75M | -37.45%3.94M | 10.35%8.05M | -29.71%4.47M | -29.71%4.47M |
| -Accounts receivable | 814.29%10.5M | -78.61%581K | -90.17%691K | -74.90%923K | -74.90%923K | -74.61%1.15M | -54.75%2.72M | 1.27%7.03M | -38.83%3.68M | -38.83%3.68M |
| -Accrued interest receivable | ---- | ---- | ---- | -49.24%403K | -49.24%403K | 14.89%602K | 321.80%1.22M | 187.36%1.02M | 127.51%794K | 127.51%794K |
| Restricted cash | ---- | ---- | --916K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | -38.51%8.43M | -6.88%11.71M | -7.61%12.61M | -34.15%12M | -34.15%12M | -23.84%13.72M | -40.43%12.57M | -8.84%13.65M | 14.91%18.22M | 14.91%18.22M |
| Total current assets | -60.61%58.13M | -74.89%40.08M | -69.78%68.64M | -68.59%94.33M | -68.59%94.33M | -56.16%147.58M | -53.48%159.61M | -33.22%227.09M | -24.69%300.33M | -24.69%300.33M |
| Non current assets | ||||||||||
| Net PPE | -33.67%36.91M | -63.45%39.29M | -60.44%42.95M | -57.89%52.87M | -57.89%52.87M | -53.99%55.65M | -12.03%107.49M | -11.37%108.57M | 0.66%125.53M | 0.66%125.53M |
| -Gross PPE | -33.67%36.91M | -63.45%39.29M | -60.44%42.95M | -35.88%103.91M | -35.88%103.91M | -53.99%55.65M | -12.03%107.49M | -11.37%108.57M | 8.24%162.06M | 8.24%162.06M |
| -Accumulated depreciation | ---- | ---- | ---- | -39.74%-51.05M | -39.74%-51.05M | ---- | ---- | ---- | -45.97%-36.53M | -45.97%-36.53M |
| Goodwill and other intangible assets | ---- | ---- | ---- | --0 | --0 | --0 | --0 | -43.73%51.56M | -5.54%88.28M | -5.54%88.28M |
| -Goodwill | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -5.42%37.55M | -5.42%37.55M |
| -Other intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.13%51.56M | -5.64%50.73M | -5.64%50.73M |
| Investments and advances | ---- | ---- | ---- | --0 | --0 | --0 | -18.62%39.04M | -56.84%35.61M | -66.15%29.85M | -66.15%29.85M |
| Non current accounts receivable | --14.72M | --13.65M | --17.37M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non current assets | -90.89%1.5M | ---- | ---- | -2.14%18.13M | -2.14%18.13M | -11.90%16.47M | 7.52%18.94M | 0.71%17.74M | 10.13%18.52M | 10.13%18.52M |
| Total non current assets | -26.33%53.13M | -68.01%52.94M | -71.74%60.33M | -72.92%70.99M | -72.92%70.99M | -71.97%72.12M | -39.61%165.47M | -32.07%213.48M | -18.87%262.18M | -18.87%262.18M |
| Total assets | -49.36%111.26M | -71.39%93.01M | -70.73%128.96M | -70.61%165.32M | -70.61%165.32M | -63.01%219.7M | -47.32%325.07M | -32.67%440.57M | -22.08%562.51M | -22.08%562.51M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 28.04%19.79M | 18.55%17.59M | -22.35%15.47M | -31.93%15.26M | -31.93%15.26M | -11.06%15.46M | 13.47%14.84M | 78.70%19.92M | 129.72%22.42M | 129.72%22.42M |
| -accounts payable | 28.04%19.79M | 18.55%17.59M | -22.35%15.47M | -31.93%15.26M | -31.93%15.26M | -11.06%15.46M | 13.47%14.84M | 78.70%19.92M | 129.72%22.42M | 129.72%22.42M |
| Current accrued expenses | -18.26%11.64M | -16.90%15.76M | 20.00%18.47M | 59.57%18.97M | 59.57%18.97M | 1.34%14.23M | 33.51%18.96M | 9.16%15.4M | 57.40%11.89M | 57.40%11.89M |
| Current debt and capital lease obligation | ---- | ---- | ---- | 11.33%4.59M | 11.33%4.59M | ---- | ---- | ---- | 2.38%4.12M | 2.38%4.12M |
| -Current capital lease obligation | ---- | ---- | ---- | 11.33%4.59M | 11.33%4.59M | ---- | ---- | ---- | 2.38%4.12M | 2.38%4.12M |
| Current deferred liabilities | -47.88%774K | ---- | ---- | --0 | --0 | -97.93%1.49M | -91.28%6.87M | -88.15%9.58M | -39.59%51.78M | -39.59%51.78M |
| Current liabilities | -10.98%43.16M | -27.49%39.01M | -30.42%40.24M | -57.27%47.73M | -57.27%47.73M | -60.38%48.48M | -55.17%53.79M | -51.20%57.84M | -12.65%111.71M | -12.65%111.71M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -20.72%27.73M | -20.00%29.1M | -18.26%30.82M | -14.03%33.52M | -14.03%33.52M | -11.91%34.98M | -12.42%36.37M | -11.94%37.7M | -11.51%38.99M | -11.51%38.99M |
| -Long term capital lease obligation | -20.72%27.73M | -20.00%29.1M | -18.26%30.82M | -14.03%33.52M | -14.03%33.52M | -11.91%34.98M | -12.42%36.37M | -11.94%37.7M | -11.51%38.99M | -11.51%38.99M |
| Non current deferred liabilities | ---- | ---- | ---- | --0 | --0 | --0 | --0 | -94.79%8.19M | -33.31%115.65M | -33.31%115.65M |
| Other non current liabilities | -5.84%1.24M | -3.55%1.22M | -1.95%1.21M | -1.66%1.19M | -1.66%1.19M | 0.46%1.32M | -1.40%1.27M | -0.57%1.23M | -0.82%1.21M | -0.82%1.21M |
| Total non current liabilities | -20.18%28.97M | -19.45%30.32M | -32.04%32.02M | -77.73%34.7M | -77.73%34.7M | -77.65%36.29M | -78.96%37.64M | -76.59%47.12M | -28.74%155.84M | -28.74%155.84M |
| Total liabilities | -14.92%72.13M | -24.18%69.32M | -31.15%72.26M | -69.19%82.43M | -69.19%82.43M | -70.23%84.78M | -69.40%91.43M | -67.18%104.96M | -22.80%267.55M | -22.80%267.55M |
| Shareholders'equity | ||||||||||
| Share capital | 17.65%2.09M | 17.56%2.08M | 18.57%2.04M | 6.77%1.78M | 6.77%1.78M | 9.51%1.77M | 15.45%1.77M | 17.11%1.72M | 14.32%1.67M | 14.32%1.67M |
| -common stock | 17.65%2.09M | 17.56%2.08M | 18.57%2.04M | 6.77%1.78M | 6.77%1.78M | 9.51%1.77M | 15.45%1.77M | 17.11%1.72M | 14.32%1.67M | 14.32%1.67M |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -10.02%-1.48B | -20.10%-1.49B | -29.10%-1.46B | -22.45%-1.41B | -22.45%-1.41B | -22.75%-1.35B | -19.02%-1.24B | -12.71%-1.13B | -20.11%-1.15B | -20.11%-1.15B |
| Paid-in capital | 2.45%1.52B | 2.66%1.52B | 3.33%1.52B | 2.88%1.49B | 2.88%1.49B | 4.41%1.49B | 7.75%1.48B | 9.46%1.47B | 8.70%1.45B | 8.70%1.45B |
| Gains losses not affecting retained earnings | 35.83%-4.22M | 0.89%-5.88M | -0.75%-5.8M | 45.32%-4.6M | 45.32%-4.6M | 65.36%-6.58M | 54.89%-5.94M | 17.21%-5.76M | -110.79%-8.4M | -110.79%-8.4M |
| Total stockholders'equity | -71.00%39.13M | -89.86%23.69M | -83.11%56.7M | -71.90%82.89M | -71.90%82.89M | -56.36%134.92M | -26.59%233.64M | 0.33%335.61M | -21.42%294.96M | -21.42%294.96M |
| Noncontrolling interests | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 | --0 |
| Total equity | -71.00%39.13M | -89.86%23.69M | -83.11%56.7M | -71.90%82.89M | -71.90%82.89M | -56.36%134.92M | -26.59%233.64M | 0.33%335.61M | -21.42%294.96M | -21.42%294.96M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
